Liberty Property Trust broke ground this week on a 45,500-square-foot building at the Philadelphia Navy Yard to be occupied by Shanghai-based WuXi AppTec. The pharmaceutical company will use its third building at the Navy Yard to manufacture new cell- and gene-based treatments for cancer and other diseases, Felix Hsu, WuXi AppTec's senior vice president for U.S. business, said in a statement. The building will be finished next year, Liberty spokeswoman Jen Meyer said.
ww.omegare.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.